Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Rosetta Genomics Ltd (NASDAQ:ROSG)

3.06
Delayed Data
As of 1:49pm ET
 -0.06 / -1.92%
Today’s Change
2.07
Today|||52-Week Range
5.55
+35.40%
Year-to-Date
Institutional investors purchased a net $956.00 shares of ROSG during the quarter ended December 2014 and now own 3.71% of the total shares outstanding. This is a greater percentage than is typical for companies in the Biotechnology industry and highlights that the smart money sees this stock as an important holding.
Other institutional3.21%
Mutual fund holders0.50%
Individual stakeholders--

Largest Quarterly Institutional
Transactions

Latest Institutional Activity

6/30/2015CREATIVE PLANNING, INC.  Sold 5.0 Thousand shares of Rosetta Genomics Ltd

Top 10 Owners of Rosetta Genomics Ltd

StockholderStakeShares
owned
Total value ($)Shares
bought / sold
Total
change
Highlander Capital Management LLC1.38%162,269550,092+38,750+31.37%
The California Public Employees R...0.43%50,609171,56500.00%
Morgan Stanley & Co. LLC0.41%48,620164,822+45,116+1,287.56%
Millennium Management LLC0.31%36,016122,094+36,016--
Philadelphia Investment Partners ...0.26%30,000101,700+8,500+39.53%
Ark Investment Management LLC0.24%28,60296,96100.00%
KCG Americas LLC0.20%23,41779,384+23,417--
Spark Investment Management LLC0.20%23,00077,970-300-1.29%
Morgan Stanley Smith Barney LLC0.10%12,10041,019+7,800+181.40%
Tower Research Capital LLC0.10%11,36838,538+9,101+401.46%

Top 10 Mutual Funds Holding Rosetta Genomics Ltd

Mutual fundStakeShares
owned
Total value ($)Shares
bought / sold
Total
change
Philadelphia Investment Partners ...0.26%30,000101,700+8,500+39.53%
ARK Genomic Revolution Multi Sect...0.24%28,60296,96100.00%
Marketocracy Masters 100 Fund0.00%00-1,000-100.00%